 | Up a level |
Tocchetti, Carlo Gabriele; Farmakis, Dimitrios; Koop, Yvonne; Andres, Maria Sol; Couch, Liam S; Formisano, Luigi; Ciardiello, Fortunato; Pane, Fabrizio; Au, Lewis; Emmerich, Max; Plummer, Chris; Gulati, Geeta; Ramalingam, Sivatharshini; Cardinale, Daniela; Brezden-Masley, Christine; Iakobishvili, Zaza; Thavendiranathan, Paaladinesh; Santoro, Ciro; Bergler-Klein, Jutta; Keramida, Kalliopi; ... (2024). Cardiovascular toxicities of immune therapies for cancer - a scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-Oncology. (In Press). European journal of heart failure Wiley 10.1002/ejhf.3340
Pizzamiglio, S; Ciniselli, C M; de Azambuja, E; Agbor-Tarh, D; Moreno-Aspitia, A; Suter, T M; Trama, A; De Santis, M C; De Cecco, L; Iorio, M V; Silvestri, M; Pruneri, G; Verderio, P; Di Cosimo, S (2024). Circulating microRNAs and therapy-associated cardiac events in HER2-positive breast cancer patients: an exploratory analysis from NeoALTTO. Breast cancer research and treatment, 206(2), pp. 285-294. Springer 10.1007/s10549-024-07299-6
Shen, Fei; Jiang, Guanglong; Philips, Santosh; Cantor, Erica; Gardner, Laura; Xue, Gloria; Cunningham, Geneva; Kassem, Nawal; O'Neill, Anne; Cameron, David; Suter, Thomas M; Miller, Kathy D; Sledge, George W; Schneider, Bryan P (2024). Germline predictors for bevacizumab induced hypertensive crisis in ECOG-ACRIN 5103 and BEATRICE. British journal of cancer, 130(8), pp. 1348-1355. Nature Publishing Group 10.1038/s41416-024-02602-0
López-Fernández, Teresa; Farmakis, Dimitrios; Ameri, Pietro; Asteggiano, Riccardo; de Azambuja, Evandro; Aznar, Marianne; Barac, Ana; Bayes-Genis, Antoni; Bax, Jeroen J; Bergler-Klein, Jutta; Boriani, Giuseppe; Celutkiene, Jelena; Coats, Andrew; Cohen-Solal, Alain; Córdoba, Raúl; Cosyns, Bernard; Filippatos, Gerasimos; Fox, Kevin; Gulati, Geeta; Inciardi, Riccardo M; ... (2024). European Society of Cardiology Core Curriculum for Cardio-Oncology. European journal of heart failure, 26(4), pp. 754-771. Wiley 10.1002/ejhf.3102
Demirel, Caglayan; Tomii, Daijiro; Heg, Dik; Okuno, Taishi; Wieser, Fabian; Suter, Thomas M; Gräni, Christoph; Windecker, Stephan; Pilgrim, Thomas (2023). Incidental detection of malignancy during pre-procedural workup for transcatheter aortic valve implantation: a longitudinal cohort study. American Heart Journal, 261, pp. 51-54. Elsevier 10.1016/j.ahj.2023.03.011
de Azambuja, E; Agostinetto, E; Procter, M; Eiger, D; Pondé, N; Guillaume, S; Parlier, D; Lambertini, M; Desmet, A; Caballero, C; Aguila, C; Jerusalem, G; Walshe, J M; Frank, E; Bines, J; Loibl, S; Piccart-Gebhart, M; Ewer, M S; Dent, S; Plummer, C; ... (2023). Cardiac safety of dual anti-HER2 blockade with pertuzumab plus trastuzumab in early HER2-positive breast cancer in the APHINITY trial. ESMO open, 8(1), p. 100772. BMJ 10.1016/j.esmoop.2022.100772
Schneider, Caroline; Ryffel, Christoph; Stütz, Laura; Rabaglio, Manuela; Suter, Thomas M; Campbell, Kristin L; Eser, Prisca; Wilhelm, Matthias (2023). Supervised exercise training in patients with cancer during anthracycline-based chemotherapy to mitigate cardiotoxicity: a randomized-controlled-trial. Frontiers in cardiovascular medicine, 10(1283153), p. 1283153. Frontiers 10.3389/fcvm.2023.1283153
Schneider, Caroline; González-Jaramillo, Nathalia; Marcin, Thimo; Campbell, Kristin L; Suter, Thomas; Bano, Arjola; Wilhelm, Matthias; Eser, Prisca (2022). Time-Dependent Effect of Anthracycline-Based Chemotherapy on Central Arterial Stiffness: A Systematic Review and Meta-Analysis. Frontiers in cardiovascular medicine, 9, p. 873898. Frontiers 10.3389/fcvm.2022.873898
Solomon, Scott D; Claggett, Brian L; Miao, Zi Michael; Diaz, Rafael; Felker, G Michael; McMurray, John J V; Metra, Marco; Corbalan, Ramon; Filippatos, Gerasimos; Goudev, Assen R; Mareev, Viatcheslav; Serpytis, Pranas; Suter, Thomas; Yilmaz, Mehmet B; Zannad, Faiez; Kupfer, Stuart; Heitner, Stephen B; Malik, Fady I; Teerlink, John R (2022). Influence of atrial fibrillation on efficacy and safety of omecamtiv mecarbil in heart failure: the GALACTIC-HF trial. European heart journal, 43(23), pp. 2212-2220. Oxford University Press 10.1093/eurheartj/ehac144
Condoluci, Adalgisa; Théaudin, Marie; Schwotzer, Rahel; Pazhenkottil, Aju P; Arosio, Paolo; Averaimo, Manuela; Bacher, Ulrike; Bode, Peter; Cavalli, Andrea; Dirnhofer, Stefan; Djerbi, Nadia; Dobner, Stephan; Fehr, Thomas; Garofalo, Maura; Gaspert, Ariana; Gerull, Sabine; Heimgartner, Raphael; Hübers, Annemarie; Jung, Hans H; Kessler, Chiara; ... (2021). Management of transthyretin amyloidosis. Swiss medical weekly, 151(w30053), w30053. EMH Media 10.4414/smw.2021.w30053
Pellegrini, Luca; Novak, Urban; Andres, Martin; Suter, Thomas; Nagler, Michael (2021). Risk of bleeding complications and atrial fibrillation associated with ibrutinib treatment: A systematic review and meta-analysis. Critical reviews in oncology/hematology, 159, p. 103238. Elsevier 10.1016/j.critrevonc.2021.103238
Schwotzer, Rahel; Flammer, Andreas J; Gerull, Sabine; Pabst, Thomas; Arosio, Paolo; Averaimo, Manuela; Bacher, Vera; Bode, Peter; Cavalli, Andrea; Concoluci, Adalgisa; Dirnhofer, Stefan; Djerbi, Nadia; Dobner, Stephan W.; Fehr, Thomas; Garofalo, Maura; Gaspert, Ariana; Heimgartner, Raphael; Hübers, Annemarie; Jung, Hans H; Kessler, Chiara; ... (2020). Expert recommendation from the Swiss Amyloidosis Network (SAN) for systemic AL-amyloidosis. Swiss medical weekly, 150(w20364), w20364. EMH Media 10.4414/smw.2020.20364
Schindera, Christina; Kuehni, Claudia Elisabeth; Pavlovic, Mladen; Haegler-Laube, Eva; Rhyner, Daniel; Waespe, Nicolas; Roessler, Jochen; Suter, Thomas M; von der Weid, Nicolas Xavier (2020). Diagnosing Preclinical Cardiac Dysfunction in Swiss ChildhoodCancer Survivors: Protocol for a Single-Center Cohort Study. JMIR research protocols, 9(6), e17724. JMIR Publications 10.2196/17724
Beauchamp, Philippe; Jackson, Christopher B.; Ozhathil, Lijo; Agarkova, Irina; Galindo, Cristi, L; Sawyer, Douglas, B; Suter, Thomas M.; Zuppinger, Christian (2020). 3D Co-culture of hiPSC-Derived Cardiomyocytes With Cardiac Fibroblasts Improves Tissue-Like Features of Cardiac Spheroids. Frontiers in Molecular Biosciences, 7, p. 14. Frontiers 10.3389/fmolb.2020.00014
Cattaneo, Magdalena Maria; Moccetti, Marco; Cattaneo, Mattia; Sürder, Daniel; Suter, Thomas; Martinelli, Michele; Roost, Eva; Schmidli, Jürg; Banz, Yara; Schneiders, Carmen; Pedrazzini, Giovanni; Corti, Roberto; Räber, Lorenz; Crea, Filippo; Mohacsi, Paul; Gallino, Augusto (2020). Intractable coronary fibromuscular dysplasia leading to end‐stage heart failure and fatal heart transplantation. ESC Heart Failure, 7(2), pp. 714-720. Wiley 10.1002/ehf2.12626
Hau, Eva M.; Caccia, Julien N; Kasteler, Rahel; Spycher, Ben; Suter, Thomas; Ammann, Roland A.; von der Weid, Nicolas X; Kuehni, Claudia E. (2019). Cardiovascular disease after childhood acute lymphoblastic leukaemia: a cohort study. Swiss medical weekly, 149, w20012. EMH Schweizerischer Ärzteverlag 10.4414/smw.2019.20012
Suter, Thomas; Novak, Urban (2017). Kardiologie: Der Preis fürs Überleben – kardiovaskuläre Nebenwirkungen onkologischer Therapien. Swiss Medical Forum, 17(03), pp. 61-63. EMH Swiss Medical Publishers 10.4414/smf.2017.02860
Schnegg, Bruno; Seiler, Jens; Suter, Thomas; Tanner, Hildegard; Servatius, Helge Simon (2016). Brugada Type 1 ECG Caused by an RVOT Tumor. The Scientific Pages of Heart, 1(1) The Scientific Pages
Zamorano, Jose Luis; Lancellotti, Patrizio; Rodriguez Muñoz, Daniel; Aboyans, Victor; Asteggiano, Riccardo; Galderisi, Maurizio; Habib, Gilbert; Lenihan, Daniel J; Lip, Gregory Y H; Lyon, Alexander R; Lopez Fernandez, Teresa; Mohty, Dania; Piepoli, Massimo F; Tamargo, Juan; Torbicki, Adam; Suter, Thomas; Zamorano, Jose Luis; Aboyans, Victor; Achenbach, Stephan; Agewall, Stefan; ... (2016). 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). European journal of heart failure, 19(1), pp. 9-42. Wiley 10.1002/ejhf.654
Beauchamp, Philippe; Ullrich, Nina; Jens, Kelm; Moritz, Wolfgang; Agarkova, Irina; Anson, Blake; Suter, Thomas; Zuppinger, Christian (2015). Development and characterization of a scaffold-free 3D spheroid model of iPSC-derived human cardiomyocytes. Tissue engineering Part C Methods, 21(8), pp. 852-861. Mary Ann Liebert 10.1089/ten.tec.2014.0376
Rutz, E; Suter, Thomas; Slongo, Theddy; Brunner, Roland (2015). Osteotomy of the distal femur. Surgical technique using the LCP Pediatric Condylar Plate 90°. Operative Orthopädie und Traumatologie, 27(3), pp. 221-236. Springer 10.1007/s00064-015-0401-0
Raschle, Joëlle; Banz Wälti, Yara; Suter, Thomas; Pabst, Thomas (2014). A single-centre cohort of patients with systemic light chain AL-amyloidosis treated with conventional chemotherapy or with high-dose chemotherapy and autologous stem cell transplantation. Swiss medical weekly, 144, w13922. EMH Schweizerischer Ärzteverlag 10.4414/smw.2014.13922
Goldhirsch, Aron; Gelber, Richard D.; Piccart-Gebhart, Martine J.; de Azambuja, Evandro; Procter, Marion; Suter, Thomas; Jackisch, Christian; Cameron, David; Weber, Harald A.; Heinzmann, Dominik; Dal Lago, Lissandra; McFadden, Eleanor; Dowsett, Mitch; Untch, Michael; Gianni, Luca; Bell, Richard; Köhne, Claus-Henning; Vindevoghel, Anita; Andersson, Michael; Brunt, A Murray; ... (2013). 2 years versus 1 year of adjuvant trastuzumab for HER2-positive breast cancer (HERA): an open-label, randomised controlled trial. Lancet, 382(9897), pp. 1021-1028. Elsevier 10.1016/S0140-6736(13)61094-6
Cameron, David; Brown, Julia; Dent, Rebecca; Jackisch, Christian; Mackey, John; Pivot, Xavier; Steger, Guenther G.; Suter, Thomas M.; Toi, Masakazu; Parmar, Mahesh; Laeufle, Rita; Im, Young-Hyuck; Romieu, Gilles; Harvey, Vernon; Lipatov, Oleg; Pienkowski, Tadeusz; Cottu, Paul; Chan, Arlene; Im, Seock-Ah; Hall, Peter S.; ... (2013). Adjuvant bevacizumab-containing therapy in triple-negative breast cancer (BEATRICE): primary results of a randomised, phase 3 trial. The lancet oncology, 14(10), pp. 933-942. Elsevier 10.1016/S1470-2045(13)70335-8
Suter, Thomas; Ewer, Michael S. (2013). Cancer drugs and the heart: importance and management. European Heart Journal, 34(15), pp. 1102-1111. Oxford University Press 10.1093/eurheartj/ehs181
Chiusa, Manuel; Hool, Sara-Lynn; Truetsch, Petra; Djafarzadeh, Siamak; Jakob, Stephan M; Seifriz, Franziska; Scherer, Stefan J; Suter, Thomas M; Zuppinger, Christian; Zbinden, Stephan (2012). Cancer therapy modulates VEGF signaling and viability in adult rat cardiac microvascular endothelial cells and cardiomyocytes. Journal of molecular and cellular cardiology, 52(5), pp. 1164-75. Oxford: Elsevier 10.1016/j.yjmcc.2012.01.022
Dimitrakis, Polychronis; Romay-Ogando, Maria-Iris; Timolati, Francesco; Suter, Thomas M; Zuppinger, Christian (2012). Effects of doxorubicin cancer therapy on autophagy and the ubiquitin-proteasome system in long-term cultured adult rat cardiomyocytes. Cell and tissue research, 350(2), pp. 361-72. Heidelberg: Springer-Verlag 10.1007/s00441-012-1475-8
Chiusa, M; Timolati, F; Perriard, J C; Suter, T M; Zuppinger, C (2012). Sodium nitroprusside induces cell death and cytoskeleton degradation in adult rat cardiomyocytes in vitro: implications for anthracycline-induced cardiotoxicity. European journal of histochemistry, 56(2), e15. Pavia: Luigi Ponzio 10.4081/ejh.2012.e15
Curigliano, G.; Cardinale, D.; Suter, T.; Plataniotis, G.; De Azambuja, E.; Sandri, M. T.; Criscitiello, C.; Goldhirsch, A.; Cipolla, C.; Roila, F. (2012). Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines. Annals of oncology, 23(suppl 7), vii155-vii166. Oxford University Press 10.1093/annonc/mds293
Lenihan, D.; Suter, T.; Brammer, M.; Neate, C.; Ross, G.; Baselga, J. (2012). Pooled analysis of cardiac safety in patients with cancer treated with pertuzumab. Annals of oncology, 23(3), pp. 791-800. Oxford University Press 10.1093/annonc/mdr294
Harbeck, N; Ewer, M S; De Laurentiis, M; Suter, T M; Ewer, S M (2011). Cardiovascular complications of conventional and targeted adjuvant breast cancer therapy. Annals of oncology, 22(6), pp. 1250-1258. Oxford: Oxford University Press 10.1093/annonc/mdq543
Rochlitz, C; Ruhstaller, T; Lerch, S; Spirig, C; Huober, J; Suter, T; Bühlmann, M; Fehr, M; Schönenberger, A; von Moos, R; Winterhalder, R; Rauch, D; Müller, A; Mannhart-Harms, M; Herrmann, R; Cliffe, B; Mayer, M; Zaman, K; Swiss Group for Clinical Cancer Research, (SAKK) (2011). Combination of bevacizumab and 2-weekly pegylated liposomal doxorubicin as first-line therapy for locally recurrent or metastatic breast cancer. A multicenter, single-arm phase II trial (SAKK 24/06). Annals of oncology, 22(1), pp. 80-5. Oxford: Oxford University Press 10.1093/annonc/mdq319
Stortecky, Stefan; Suter, Thomas M (2010). Insights into cardiovascular side-effects of modern anticancer therapeutics. Current opinion in oncology, 22(4), pp. 312-7. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1097/CCO.0b013e32833ab6f1
Zuppinger, Christian; Suter, Thomas M (2010). Cancer therapy-associated cardiotoxicity and signaling in the myocardium. Journal of cardiovascular pharmacology, 56(2), pp. 141-6. Hagerstown, Md.: Wolters Kluwer Lippincott Williams & Wilkins 10.1097/FJC.0b013e3181e0f89a
Procter, Marion; Suter, Thomas M; de Azambuja, Evandro; Dafni, Urania; van Dooren, Veerle; Muehlbauer, Susanne; Climent, Miguel Angel; Rechberger, Ernst; Liu, Walter Tsang-Wu; Toi, Mazakasu; Coombes, R Charles; Dodwell, David; Pagani, Olivia; Madrid, Jorge; Hall, Marcia; Chen, Shin-Cheh; Focan, Christian; Muschol, Michael; van Veldhuisen, Dirk J and Piccart-Gebhart, Martine J (2010). Longer-term assessment of trastuzumab-related cardiac adverse events in the Herceptin Adjuvant (HERA) trial. Journal of clinical oncology, 28(21), pp. 3422-8. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2009.26.0463
Timolati, Francesco; Anliker, Tobias; Groppalli, Vittoria; Perriard, Jean-Claude; Eppenberger, Hans M; Suter, Thomas M; Zuppinger, Christian (2009). The role of cell death and myofibrillar damage in contractile dysfunction of long-term cultured adult cardiomyocytes exposed to doxorubicin. Cytotechnology, 61(1-2), pp. 25-36. Dordrecht: Springer Netherlands 10.1007/s10616-009-9238-4
Pentassuglia, Laura; Graf, Michael; Lane, Heidi; Kuramochi, Yukio; Cote, Gregory; Timolati, Francesco; Sawyer, Douglas B; Zuppinger, Christian; Suter, Thomas M (2009). Inhibition of ErbB2 by receptor tyrosine kinase inhibitors causes myofibrillar structural damage without cell death in adult rat cardiomyocytes. Experimental cell research, 315(7), pp. 1302-12. San Diego, Calif.: Elsevier 10.1016/j.yexcr.2009.02.001
Noti, F; Zimmerli, S; Goerre, S; Carrel, T; Suter, T (2009). [Does yoghurt gnaw at cardiac valves?]. Praxis - schweizerische Rundschau für Medizin, 98(10), pp. 547-50. Bern: Huber
de Azambuja, Evandro; Bedard, Philippe L; Suter, Thomas; Piccart-Gebhart, Martine (2009). Cardiac toxicity with anti-HER-2 therapies: what have we learned so far? Targeted oncology, 4(2), pp. 77-88. Paris: Springer 10.1007/s11523-009-0112-2
Pfisterer, Matthias; Buser, Peter; Rickli, Hans; Gutmann, Marc; Erne, Paul; Rickenbacher, Peter; Vuillomenet, André; Jeker, Urs; Dubach, Paul; Beer, Hansjürg; Yoon, Se-Il; Suter, Thomas; Osterhues, Hans H; Schieber, Michael M; Hilti, Patrick; Schindler, Ruth; Brunner-La Rocca, Hans-Peter (2009). BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial. JAMA - the journal of the American Medical Association, 301(4), pp. 383-92. Chicago, Ill.: American Medical Association 10.1001/jama.2009.2
Rayson, D.; Richel, D.; Chia, S.; Jackisch, C.; Van Der Vegt, S.; Suter, T. (2008). Anthracycline–trastuzumab regimens for HER2/neu-overexpressing breast cancer: current experience and future strategies. Annals of oncology, 19(9), pp. 1530-1539. Oxford University Press 10.1093/annonc/mdn292
Pentassuglia, Laura; Timolati, Francesco; Seifriz, Franziska; Abudukadier, Kaisaier; Suter, Thomas M; Zuppinger, Christian (2007). Inhibition of ErbB2/neuregulin signaling augments paclitaxel-induced cardiotoxicity in adult ventricular myocytes. Experimental cell research, 313(8), pp. 1588-601. San Diego, Calif.: Elsevier 10.1016/j.yexcr.2007.02.007
Zuppinger, Christian; Timolati, Francesco; Suter, Thomas M (2007). Pathophysiology and diagnosis of cancer drug induced cardiomyopathy. Cardiovascular toxicology, 7(2), pp. 61-6. New York, N.Y.: Humana Press Inc 10.1007/s12012-007-0016-2
Suter, Thomas M; Procter, Marion; van Veldhuisen, Dirk J; Muscholl, Michael; Bergh, Jonas; Carlomagno, Chiara; Perren, Timothy; Passalacqua, Rodolfo; Bighin, Claudia; Klijn, Jan G M; Ageev, Fail T; Hitre, Erika; Groetz, Juergen; Iwata, Hiroji; Knap, Malgorzata; Gnant, Michael; Muehlbauer, Susanne; Spence, Alison; Gelber, Richard D and Piccart-Gebhart, Martine J (2007). Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial. Journal of clinical oncology, 25(25), pp. 3859-65. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2006.09.1611
Timolati, Francesco; Ott, Daniel; Pentassuglia, Laura; Giraud, Marie-Noëlle; Perriard, Jean-Claude; Suter, Thomas M; Zuppinger, Christian (2006). Neuregulin-1 beta attenuates doxorubicin-induced alterations of excitation-contraction coupling and reduces oxidative stress in adult rat cardiomyocytes. Journal of molecular and cellular cardiology, 41(5), pp. 845-54. Oxford: Elsevier 10.1016/j.yjmcc.2006.08.002
Suter, T. M.; Meier, B. (2002). Detection of anthracycline-induced cardiotoxicity: is there light at the end of the tunnel? Annals of oncology, 13(5), pp. 647-649. Oxford University Press 10.1093/annonc/mdf231
